Science 

University of California to be granted pioneering CRISPR patent

(Reuters) – The University of California will soon be granted a potentially valuable patent on the revolutionary gene-editing technology known as CRISPR, according to a document filed by the U.S. patent office on Friday. The U.S. Patent and Trademark Office decision to grant the patent could further fuel a long-running rivalry between the university and the Broad Institute, a biological and genomic research center affiliated with the Massachusetts Institute of Technology (MIT) and Harvard University that also holds patents on CRISPR. Patent rights to CRISPR could eventually be worth billions…

Read More
Science 

University of California to be granted CRISPR patent

NEW YORK (Reuters) – The University of California will soon be granted a potentially valuable patent on the revolutionary gene-editing technology known as CRISPR, according to a document filed by the U.S. patent office on Friday.     The decision by the U.S. Patent and Trademark Office to grant the patent could further fuel a long-running dispute between the university and the Broad Institute, a biological and genomic research center affiliated with the Massachusetts Institute of Technology (MIT) and Harvard that also holds patents on CRISPR.     Patent rights to CRISPR…

Read More
Science 

U.S. appeals court upholds MIT, Harvard patents on CRISPR gene editing

(Reuters) – A U.S. appeals court on Monday allowed a research center affiliated with the Massachusetts Institute of Technology and Harvard University to keep patents potentially worth billions of dollars on a groundbreaking gene editing technology known as CRISPR. The U.S. Court of Appeals for the Federal Circuit affirmed the validity of the Harvard and MIT patents, rejecting a challenge brought by a rival team of researchers associated with the University of California at Berkeley and University of Vienna in Austria. Shares of Cambridge, Massachusetts-based Editas Medicine Inc, a biotechnology…

Read More